• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".

作者信息

Wells Martin T, Eisenberg Theodore

出版信息

Circulation. 2010 Dec 7;122(23):e575; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.953216.

DOI:10.1161/CIRCULATIONAHA.110.953216
PMID:21135368
Abstract
摘要

相似文献

1
Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".韦尔斯和艾森伯格就《他汀类药物用于高敏C反应蛋白升高或血脂异常女性心血管事件一级预防：来自他汀类药物预防的理由：一项评估瑞舒伐他汀的干预试验（JUPITER）及一级预防试验女性荟萃分析》一文所写的信函
Circulation. 2010 Dec 7;122(23):e575; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.953216.
2
Letter by Vos et al regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".沃斯等人就文章《他汀类药物用于高敏C反应蛋白升高或血脂异常女性心血管事件一级预防：来自他汀类药物在预防中的应用理由：一项评估瑞舒伐他汀的干预试验（JUPITER）及一级预防试验女性荟萃分析的结果》所写的信。
Circulation. 2010 Dec 7;122(23):e576; author reply e577. doi: 10.1161/CIRCULATIONAHA.110.954016.
3
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?他汀类药物用于一级预防的理由：一项评估瑞舒伐他汀的干预试验（JUPITER）——C反应蛋白能否用于指导一级预防中的他汀类药物治疗？
Am J Cardiol. 2006 Jan 16;97(2A):33A-41A. doi: 10.1016/j.amjcard.2005.11.014. Epub 2005 Dec 1.
4
Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).在低密度脂蛋白胆固醇水平低且高敏C反应蛋白升高的男性和女性中，使用瑞舒伐他汀预防首次心血管事件和死亡的需治疗人数：他汀类药物用于预防的依据：一项评估瑞舒伐他汀的干预试验（JUPITER）
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):616-23. doi: 10.1161/CIRCOUTCOMES.109.848473. Epub 2009 Sep 22.
5
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.美国低密度脂蛋白胆固醇水平低且高敏C反应蛋白升高的患病率：JUPITER（他汀类药物在一级预防中的应用：评估瑞舒伐他汀的干预试验）研究的启示
J Am Coll Cardiol. 2009 Mar 17;53(11):931-5. doi: 10.1016/j.jacc.2008.12.010.
6
The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).JUPITER研究（他汀类药物在一级预防中的应用理由：一项评估瑞舒伐他汀的干预试验）
Postgrad Med. 2009 May;121(3):113-8. doi: 10.3810/pgm.2009.05.2010.
7
Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.高C反应蛋白水平患者血管事件的一级预防：JUPITER研究
Expert Rev Cardiovasc Ther. 2009 Sep;7(9):1041-56. doi: 10.1586/erc.09.93.
8
Another look at the results of the JUPITER trial.再看 JUPITER 试验的结果。
Am J Cardiol. 2009 Dec 1;104(11):1603-5. doi: 10.1016/j.amjcard.2009.07.033. Epub 2009 Oct 14.
9
The JUPITER trial: How will it change clinical practice?JUPITER试验：它将如何改变临床实践？
Rev Cardiovasc Med. 2009 Spring;10(2):91-6.
10
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.对于高敏 C 反应蛋白升高或血脂异常的女性，用他汀类药物进行心血管一级预防：来自评估瑞舒伐他汀用于预防的应用（JUPITER）的干预试验和来自一级预防试验的女性亚组的荟萃分析的结果。
Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22.